pembrolizumab,lenvatinib
eisai,merck
['hcc', 'leap-002', 'lenva']
#esmo22 richard finn is on the stage! presenting leap-002 results let s get his insights whether lenvatinib as a comparator was a suitable choice for the study design #hcc 
Independent and international group of experts in Liver oncology. Part of https://t.co/GxDpwbRI4D

#HCC #MedEd #oncology #LiverTwitter